Sorry, you need to enable JavaScript to visit this website.

Competitive Grants Program

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Optimizing the Experience of Patients with Bladder Cancer Through Multi-Disciplinary Care
    Release Date:
    Partner: Conquer Cancer, the ASCO Foundation
    Review Process: Expert Review Panel
    Quality Improvement Oncology USA
    The Enhancement of Management of breast cancer in French speaking Sub-Saharan African Countries
    Release Date:
    Partner: AMFROM
    Review Process: Expert Review Panel
    Translation: French (link)
    Quality Improvement Oncology Benin, Congo, The Democratic Republic, Mali, Senegal, Togo
    Clinical Updates and Strategies in the Treatment and Management of First-line BRAF V600E-mutant Metastatic Colorectal Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Guidelines and Best Practices in the Holistic Management of Patients with Metastatic Urothelial Carcinoma (mUC)
    Release Date:
    Partner: Astellas
    Review Process: Pfizer Internal
    Education Oncology USA
    Improving Atopic Dermatitis and Alopecia Areata Quality of Care to Standardize Management
    Release Date:
    Partner: Beijing Guangda Precision Medicine Research Center
    Review Process: Expert Review Panel
    Quality Improvement Inflammation & Immunology China
    Post-COVID Conditions: Potential Diagnosis, Testing, Management, and Ongoing Research
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines USA
    Optimizing Antimicrobial Stewardship Program in Saudi Arabia
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Inflammation & Immunology Saudi Arabia
    Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple Myeloma
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology All
    Shared Decision Making in Hemophilia Patient Care
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease USA
    Invasive Mold Infections (IMI) - Real-World Evidence from Treatment Outcomes with Isavuconazole
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology Australia, Germany, Israel, Italy, Spain, Switzerland
    Optimizing maternal immunization practice in Malaysia Indonesia Singapore Philippines
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Vaccines Indonesia, Malaysia, Philippines, Singapore
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    COVID-19 Epidemiology Research
    Release Date:
    Review Process: Pfizer Internal
    Research Vaccines Algeria, Egypt, Indonesia, Lebanon, Philippines, Thailand, Tunisia, Vietnam
    Latin America Needs Assessment of Mental Health
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine Argentina, Belize, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Uruguay, Venezuela
    Raising Awareness and Promoting Timely Diagnosis of TTR Amyloidosis
    Release Date:
    Partner: Mayo Clinic
    Review Process: Expert Review Panel
    Translation: French (link)
    Translation: Spanish (link)
    Translation: Mandarin (link)
    Translation: Arabic (link)
    Quality Improvement Rare Disease All
    Identifying and Diagnosing Juvenile Idiopathic Arthritis (JIA)
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Antibiotic Stewardship in Pediatrics
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Hospital All
    China Educational Needs Assessment in Atopic Dermatitis
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology China
    China Medical Education in Atopic Dermatitis Awareness and Treatment
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology China
    Educational Activities to Improve Vaccination Rate beyond Clinical Departments
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines Japan
    Appropriate Immunization among Patients with Immune-Mediated Inflammatory Diseases (IMIDs)
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Inflammation & Immunology All
    Promoting Pain Treatment in Osteoarthritis Care
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine Japan
    Improve the Treatment Environment for Cancer Pain Patients
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine Japan
    Improving the Knowledge Gap on Vaccine Safety Assessment
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines Japan